Lysine demethylase 6B (KDM6B) was overexpressed in GBM tissues and treatment with KDM5B specific inhibitor GSK-J4 significantly improved survival in GBM models of diffuse intrinsic pontine gliomas. This evidence concerns the gene KDM6B and diffuse intrinsic pontine glioma.